Antidepressant brain fog
Antidepressant brain fog is the everyday name for feeling slow, fuzzy or forgetful while taking an antidepressant: words go missing, you read the same page twice, following a conversation takes effort. It is not a term that appears on US labels, which use words such as drowsiness (somnolence), tiredness and confusion. Depression itself often causes the same problems, so it can be hard to tell which is to blame. Tell your prescriber if it is getting in the way, and get checked promptly if confusion is new or getting worse, especially if you are older.
Also called: SSRI brain fog, Brain fog.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
What is antidepressant brain fog?
Nothing measures it in the clinic, which is why two people using the same words can mean different things. One means sleepiness, another means losing the thread mid-sentence, a third means a day that costs more effort than it used to. Saying which one you mean is what makes the word usable at an appointment.
The labels count the nearest things instead. Somnolence and fatigue have numbers on them, and confusional state sits among the reactions reported in fewer than 2% of people on sertraline.
How common is feeling drowsy or foggy on an antidepressant?
Drowsiness and tiredness are common and counted. On the Zoloft label, in trials pooled across six conditions, depression, OCD, panic disorder, PTSD, social anxiety disorder and premenstrual dysphoric disorder, with 3,066 adults on sertraline, somnolence was reported by 11% of people against 6% on placebo, and fatigue by 12% against 8%.
Those are one drug's numbers. Every antidepressant has its own, and they differ a lot from drug to drug, so the figures that apply to you are the ones on your own label or the ones your prescriber can quote.
Is brain fog the medication or the depression?
Both happen, and what tells them apart is timing. Fog that arrived with a new prescription, or within days of a dose change, points at the medication. Fog that was there before you started and sits alongside a low mood points at the depression. Sleep is the third thing to check, because a medication that breaks your nights costs you concentration the next day, and that is a different problem from the medicine slowing your thinking directly.
There is a fourth, and it shows on a blood test. The Zoloft label lists difficulty concentrating, memory impairment and confusion among the signs of low sodium, along with headache, weakness and unsteadiness, and says older people, people taking diuretics and people who are volume-depleted may be at greater risk. That one is worth naming at the appointment, because someone can check it.
The numbers behind the depression side are solid. A 2014 meta-analysis in Psychological Medicine found moderate deficits in executive function, memory and attention during a depressive episode, with effect sizes of about -0.34 to -0.65 against healthy comparison groups. In people in remission, deficits in executive function and attention were still there, about -0.52 to -0.61, while memory was affected less. The authors call cognitive impairment a core feature of depression.
Antidepressants, on average, move it the other way, and the average rests mostly on two drugs. A 2015 systematic review and meta-analysis of 9 placebo-controlled trials with 2,550 people found small improvements in psychomotor speed and in delayed recall, while cognitive control and executive function did not reach significance. Most of those people were taking vortioxetine, 728, or duloxetine, 714; the SSRIs came to 156 people in all, 84 on citalopram, 49 on sertraline and 23 on paroxetine. The psychomotor finding lost its significance once vortioxetine was taken out of the analysis, and 8 trials comparing classes head to head found no significant difference between them.
For older adults there is newer work. A 2024 systematic review and meta-analysis in the American Journal of Psychiatry looked at cognition after antidepressant treatment for late-life depression and found an overall improvement in memory and learning across 8 studies with 493 people, with the most consistent results for sertraline, where all five of its studies pointed the same way.
Can brain fog come from stopping or missing doses?
Yes, and it reads differently. This is antidepressant discontinuation syndrome, and confusion is on the list of reactions reported after stopping a serotonergic antidepressant, especially an abrupt stop, next to dizziness, lethargy, irritability, sensory disturbances such as the electric shock sensations people call brain zaps, insomnia and headache. Fog that starts a few days after a cut or a missed dose points at the change rather than at the medicine you have taken for months.
If the fog is getting worse, or your mood is dropping with it, tell your prescriber rather than waiting for the next appointment.
What to do
Date it: when the fog started, what dose you were on, whether anything changed in the two weeks before, and how you have been sleeping. Bring one concrete example, like rereading the same email three times, which is easier to judge than the word fog. Ask your prescriber whether sleep, the timing of your dose, a blood test or the medication itself is the first thing to look at, and what else they would want to rule out. If your mood drops with it, or you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number.
Side effects in the first two weeks
How withClaro helps
- Log brain fog and sleep each day, next to your dose
- See whether it started with a dose change
- Share a PDF report with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Zoloft (sertraline) tablets and oral solution: prescribing information. FDA / DailyMed, 2025.
- Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychological Medicine, 2014.
- Rosenblat JD, Kakar R, McIntyre RS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. International Journal of Neuropsychopharmacology, 2015.
- Ainsworth NJ, Marawi T, Maslej MM, Blumberger DM, Rajji TK. Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis. American Journal of Psychiatry, 2024.
All glossary terms